Nisa Investment Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15M Sell
171,647
-64,459
-27% -$6.18M 0.06% 202
2025
Q4
$22.9M Buy
236,106
+13,474
+6% +$1.31M 0.08% 151
2025
Q3
$21.4M Sell
222,632
-191,790
-46% -$17.6M 0.08% 157
2025
Q2
$36.4M Sell
414,422
-16,890
-4% -$1.43M 0.16% 100
2025
Q1
$39.1M Sell
431,312
-123,338
-22% -$11M 0.2% 90
2024
Q4
$44.7M Buy
554,650
+84,125
+18% +$7.28M 0.17% 87
2024
Q3
$42.7M Buy
470,525
+137,429
+41% +$11.6M 0.25% 80
2024
Q2
$26.5M Sell
333,096
-5,407
-2% -$443K 0.17% 125
2024
Q1
$29.7M Buy
338,503
+311
+0.1% +$26.5K 0.19% 111
2023
Q4
$27.9M Buy
338,192
+1,373
+0.4% +$105K 0.2% 115
2023
Q3
$26.4M Sell
336,819
-32,495
-9% -$2.72M 0.2% 117
2023
Q2
$32.5M Sell
369,314
-17,721
-5% -$1.53M 0.24% 88
2023
Q1
$31.2M Buy
387,035
+16,136
+4% +$1.32M 0.24% 90
2022
Q4
$28.8M Buy
370,899
+5,538
+2% +$449K 0.23% 104
2022
Q3
$29.6M Buy
365,361
+5,454
+2% +$490K 0.25% 84
2022
Q2
$32.3M Sell
359,907
-36,320
-9% -$3.68M 0.28% 75
2022
Q1
$44M Sell
396,227
-19,147
-5% -$2.02M 0.31% 69
2021
Q4
$43M Buy
415,374
+10,354
+3% +$1.2M 0.32% 70
2021
Q3
$50.8K Sell
405,020
-14,860
-4% -$1.92M 0.31% 68
2021
Q2
$52.1K Sell
419,880
-53,216
-11% -$6.68M 0.33% 64
2021
Q1
$55.9K Sell
473,096
-14,340
-3% -$1.68M 0.35% 57
2020
Q4
$57.1M Buy
487,436
+11,070
+2% +$1.22M 0.37% 62
2020
Q3
$49.5M Sell
476,366
-68,925
-13% -$6.92M 0.4% 54
2020
Q2
$50M Buy
545,291
+14,013
+3% +$1.34M 0.46% 47
2020
Q1
$47.9M Sell
531,278
-19,832
-4% -$2.11M 0.53% 40
2019
Q4
$62.5M Buy
551,110
+57,224
+12% +$6.28M 0.54% 37
2019
Q3
$53.6M Sell
493,886
-18,637
-4% -$1.94M 0.48% 42
2019
Q2
$49.9M Sell
512,523
-56,036
-10% -$5.12M 0.47% 43
2019
Q1
$51.8M Sell
568,559
-12,949
-2% -$1.16M 0.5% 42
2018
Q4
$52.9M Sell
581,508
-992
-0.2% -$92.7K 0.59% 37
2018
Q3
$57.3M Buy
582,500
+99,658
+21% +$9.21M 0.52% 39
2018
Q2
$41.3M Buy
482,842
+15,306
+3% +$1.28M 0.43% 51
2018
Q1
$37.5M Sell
467,536
-14,000
-3% -$1.15M 0.39% 59
2017
Q4
$38.9M Sell
481,536
-5,038
-1% -$403K 0.4% 53
2017
Q3
$37.8M Buy
486,574
+60,976
+14% +$5.06M 0.43% 51
2017
Q2
$37.6M Buy
425,598
+48,413
+13% +$4.08M 0.44% 45
2017
Q1
$30.4M Buy
377,185
+1,523
+0.4% +$119K 0.36% 57
2016
Q4
$26.8M Sell
375,662
-63,117
-14% -$4.96M 0.33% 60
2016
Q3
$37.9M Buy
438,779
+31,797
+8% +$2.77M 0.49% 41
2016
Q2
$35.3M Buy
406,982
+42,341
+12% +$3.42M 0.47% 44
2016
Q1
$27.3M Sell
364,641
-42,580
-10% -$3.21M 0.39% 50
2015
Q4
$31.3M Sell
407,221
-5,606
-1% -$422K 0.45% 46
2015
Q3
$27.9M Sell
412,827
-9,712
-2% -$715K 0.43% 49
2015
Q2
$31.3M Sell
422,539
-12,825
-3% -$980K 0.44% 47
2015
Q1
$34M Buy
435,364
+70,713
+19% +$5.36M 0.47% 46
2014
Q4
$26.3M Sell
364,651
-7,356
-2% -$511K 0.36% 61
2014
Q3
$23M Buy
372,007
+13,200
+4% +$839K 0.32% 67
2014
Q2
$22.9M Sell
358,807
-17,053
-5% -$1.04M 0.32% 67
2014
Q1
$23.1M Sell
375,860
-7,108
-2% -$414K 0.33% 66
2013
Q4
$22M Sell
382,968
-13,199
-3% -$748K 0.31% 68
2013
Q3
$21.1M Sell
396,167
-24,648
-6% -$1.33M 0.32% 65
2013
Q2
$21.7M Buy
+420,815
New +$20.8M 0.34% 63

Other funds holding MDT

Nisa Investment Advisors's MDT Position: Q1 2026 in Review

Nisa Investment Advisors reduced its Medtronic (MDT) stake by 27% in Q1 2026, selling an estimated $6.18M and leaving 171,647 shares worth $15M. The position accounts for 0.06% of the portfolio, ranked #202.

Nisa Investment Advisors first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $62.5M in Q4 2019. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Nisa Investment Advisors held 171,647 shares of Medtronic worth $15M as of Q1 2026.
  • Nisa Investment Advisors sold 64,459 Medtronic shares in Q1 2026, an estimated $6.18M.
  • Medtronic made up 0.06% of Nisa Investment Advisors's portfolio in Q1 2026, its #202 holding.
  • Nisa Investment Advisors first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Nisa Investment Advisors's Medtronic position peaked at $62.5M in Q4 2019.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.